[1]
“Case Report on Adjunct Intravenous Autologous Activated Platelet-Rich Plasma Therapy in Severely Ill COVID-19 Patients”, Biomed. Res. Ther., vol. 8, no. 10, pp. 4614–4619, Oct. 2021, doi: 10.15419/bmrat.v8i10.697.